Cancer vaccine could ‘boost’ immunotherapy effectiveness
A major new study has discovered a means to increase [...]
PARP inhibitors, vaccines and combination therapies for kidney cancer
In this interview with OncLive, professor Sumanta Kumar Pal from [...]
Potential new treatments for kidney cancer discussed at 2019 Kidney Cancer Research Summit
In this interview from the 2019 Kidney Cancer Research Summit [...]
Personalised immunotherapy for advanced kidney cancer
In this video interview, Dr David Braun from the Dana-Farber [...]
Personalised vaccine to be tested in patients with kidney cancer
Scientists at the Dana-Farber Cancer Institute in Boston, USA, are [...]
Kidney cancer vaccine abandoned after failure of phase 3 clinical trial
Argos Therapeutics has abandoned its phase 3 trial of rocapuldencel-T (a [...]
Cancer-killing virus acts by triggering the immune system
A study published in Cancer Research last week has shown [...]
Kidney cancer vaccine shows promise in early clinical trial
Results from a phase I clinical trial of a vaccine [...]
Cancer vaccine ilixadencel triggers strong immune response in newly diagnosed kidney cancer tumours
Results from the first phase of a phase 1/2 clinical [...]
Follow-up data from phase I/II clinical trial with INTUVAX in kidney cancer shows promise
Follow-up data from a phase I/II clinical trial with INTUVAX [...]
